NMDA receptor antagonists in the treatment of neurological diseases
The paper reviews clinical trials evaluating the efficacy of N-methyl-D-aspartate (NMDA) receptor antagonists used to treat various neurological diseases: neurodegenerative dementias, vascular cognitive disorders, including post-stroke cognitive impairment. It discusses the possibility of treating c...
Saved in:
| Main Author: | I. S. Preobrazhenskaya |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2020-10-01
|
| Series: | Неврология, нейропсихиатрия, психосоматика |
| Subjects: | |
| Online Access: | https://nnp.ima-press.net/nnp/article/view/1450 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modern aspects of diagnosis and treatment of cognitive impairments (literature review)
by: A. B. Lokshina, et al.
Published: (2023-02-01) -
Non-drug therapies for cognitive impairment
by: I. S. Preobrazhenskaya, et al.
Published: (2019-06-01) -
Outpatient management of patients with dyscirculatory encephalopathy
by: V. A. Parfenov, et al.
Published: (2015-03-01) -
NMDA receptors antagonists alleviated the acute phase of traumatic brain injury
by: Mehrdad Hajinejad, et al.
Published: (2025-02-01) -
Delayed Speech in Children as a Symptom; Socio-demographic Features and Accompanying Clinical Diagnosis
by: Damla Eyuboglu, et al.
Published: (2019-04-01)